Last updated on October 2018

A Study Investigating Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD)


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Premenstrual Dysphoric Disorder
  • Age: Between 18 - 45 Years
  • Gender: Female

Main Inclusion Criteria:

  • have PMDD according to DSM-5 verified in two menstrual cycles
  • have a regular menstrual cycle of 24-35 days cycle,
  • use double barrier contraception, non-hormonal IUD, be truly sexually abstinent, or subject or her partner has been surgically sterilized,

Main Exclusion Criteria:

  • steroid hormonal treatment or treatment with psychopharmaceuticals during previous three months
  • treatments for premenstrual syndrome (PMS) or PMDD
  • history of or significant medical condition ongoing
  • be pregnant or plan a pregnancy within the study period

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.